Tiansuo Zhao

Tiansuo Zhao

Tianjin Key Laboratory Of Digestive Cancer, Key Laboratory Of Cancer Prevention And Therapy
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.

Journal: Signal transduction and targeted therapy

Published: January 03, 2026

Epithelial FOXP3 Orchestrates O-Glycosylated IL6 Secretion to Drive Pancreatic Fibrocarcinogenesis.

Epithelial FOXP3 Orchestrates O-Glycosylated IL6 Secretion to Drive Pancreatic Fibrocarcinogenesis.

Journal: Gastroenterology

Published: October 05, 2025

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

Journal: Cancer biology & medicine

Published: September 30, 2025

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters.

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters.

Journal: Cancer biology & medicine

Published: September 27, 2025

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Journal: Cancer discovery

Published: September 18, 2025

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.

Journal: Nature communications

Published: August 28, 2025

Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade.

Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade.

Journal: Gut

Published: May 05, 2025

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.

Journal: Signal transduction and targeted therapy

Published: April 16, 2025

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Journal: Cancer discovery

Published: February 26, 2025

A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma.

A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma.

Journal: Cell reports. Medicine

Published: January 29, 2025

Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study.

Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 25, 2024

Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma.

Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma.

Journal: The Journal of surgical research

Published: September 20, 2024

Showing 1-12 of 66

Last Updated: 09/26/2026